1. AOYAMA, H.; TAGO, Masao; KATO, Norio; et al. Neurocognitive Function of Patients with Brain Metastasis Who Received Either Whole Brain Radiotherapy Plus Stereotactic Radiosurgery or Radiosurgery Alone. v. 68, n. 5, p. 1388–1395, 2007. Disponível em: https://pubmed.ncbi.nlm.nih.gov/17674975/. Acesso em: 23 jun. 2024.
2. BOLDRINI, L.; BIBAULT, Jean-Emmanuel; MASCIOCCHI, Carlotta; et al. Deep Learning: A Review for the Radiation Oncologist. Frontiers in Oncology, v. 9, 2019. Disponível em: . Acesso em: 23 jun. 2024.
3. BROWN, P. D; BALLMAN, Karla V; CERHAN, Jane H; et al. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. The Lancet Oncology, v. 18, n. 8, p. 1049–1060, 2017. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568757/. Acesso em: 23 jun. 2024.
4. BROWN, P. D; JAECKLE, Kurt; BALLMAN, Karla V; et al. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. JAMA, v. 316, n. 4, p. 401–409, 2016. Disponível em: https://www.ncbi.nlm.nih.gov/pubmed/27458945. Acesso em: 23 jun. 2024.
5. BUCHER-MALUSCHKE, J. S. N. F.; FIALHO, Roberta Barreira Massler; PEDROSO, Janari da Silva; et al. Dinâmica familiar no contexto do paciente oncológico. Revista do NUFEN, v. 6, n. 1, p. 87–108, 2014. Disponível em: http://pepsic.bvsalud.org/scielo.php?script=sci_arttext&pid=S2175-25912014000100005. Acesso em: 23 jun. 2024.